Kaplan–Meier curve showing 24-month cumulative primary patency stratified by venographic and procedural factors.
<p>Each graph shows the cumulative primary patency rates among patients with and without specific risk factors. Differences in the survival distribution were assessed using log-rank tests. <b>A.</b> Venous stenosis. Patients with stenosis ≥50% showed significantly lower patency com...
Saved in:
| 主要作者: | |
|---|---|
| 其他作者: | , , , , , |
| 出版: |
2025
|
| 主题: | |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|
| _version_ | 1849927627603705856 |
|---|---|
| author | Chang Hoon Oh (16786347) |
| author2 | In Chul Nam (11307676) Doo Ri Kim (14059684) Jung Ho Won (7871465) Hyoung Nam Lee (14106504) Sung-Joon Park (548075) Youngjong Cho (10052659) |
| author2_role | author author author author author author |
| author_facet | Chang Hoon Oh (16786347) In Chul Nam (11307676) Doo Ri Kim (14059684) Jung Ho Won (7871465) Hyoung Nam Lee (14106504) Sung-Joon Park (548075) Youngjong Cho (10052659) |
| author_role | author |
| dc.creator.none.fl_str_mv | Chang Hoon Oh (16786347) In Chul Nam (11307676) Doo Ri Kim (14059684) Jung Ho Won (7871465) Hyoung Nam Lee (14106504) Sung-Joon Park (548075) Youngjong Cho (10052659) |
| dc.date.none.fl_str_mv | 2025-11-25T18:33:04Z |
| dc.identifier.none.fl_str_mv | 10.1371/journal.pone.0336037.g003 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/figure/Kaplan_Meier_curve_showing_24-month_cumulative_primary_patency_stratified_by_venographic_and_procedural_factors_/30714271 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biochemistry Medicine Cell Biology Molecular Biology Biotechnology Developmental Biology Cancer Infectious Diseases multivariate cox model kaplan &# 8211 iliofemoral dvt secondary effective anatomical resolution 28 – 19 month venous patency related confounding factors meier survival analysis term venous patency independently predict patency hr ]= 5 term patency reduced patency procedural factors independently associated xlink "> whereas 17 venographic findings univariate analysis thurner syndrome stent placement stent deployment prospective studies prognostic significance prognostic impact primary outcome persistent collaterals likely due january 2011 independent predictor hazard ratio confidence interval better outcomes april 2023 05 ). 021 ). |
| dc.title.none.fl_str_mv | Kaplan–Meier curve showing 24-month cumulative primary patency stratified by venographic and procedural factors. |
| dc.type.none.fl_str_mv | Image Figure info:eu-repo/semantics/publishedVersion image |
| description | <p>Each graph shows the cumulative primary patency rates among patients with and without specific risk factors. Differences in the survival distribution were assessed using log-rank tests. <b>A.</b> Venous stenosis. Patients with stenosis ≥50% showed significantly lower patency compared to those with <50% stenosis (<i>p</i> < 0.001). <b>B.</b> Venous spur. Presence of luminal irregularity (spur) was associated with inferior patency outcomes (<i>p</i> < 0.001). <b>C.</b> Persistent Collateral Veins. Patients without collateral flow demonstrated significantly higher patency rates than those with persistent collateral flow (<i>p</i> = 0.001). <b>D.</b> Stent placement. Patients who underwent stent placement had a higher long-term patency than those who did not (<i>p</i> = 0.019). <b>E.</b> Stent diameter. Among patients with stent placement, no significant difference in patency was observed between stents ≤12 mm and >12 mm in diameter (<i>p</i> = 0.332).</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_34b5305ef83f81c63a969d33b7530b5d |
| identifier_str_mv | 10.1371/journal.pone.0336037.g003 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30714271 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | Kaplan–Meier curve showing 24-month cumulative primary patency stratified by venographic and procedural factors.Chang Hoon Oh (16786347)In Chul Nam (11307676)Doo Ri Kim (14059684)Jung Ho Won (7871465)Hyoung Nam Lee (14106504)Sung-Joon Park (548075)Youngjong Cho (10052659)BiochemistryMedicineCell BiologyMolecular BiologyBiotechnologyDevelopmental BiologyCancerInfectious Diseasesmultivariate cox modelkaplan &# 8211iliofemoral dvt secondaryeffective anatomical resolution28 – 19month venous patencyrelated confounding factorsmeier survival analysisterm venous patencyindependently predict patencyhr ]= 5term patencyreduced patencyprocedural factorsindependently associatedxlink ">whereas 17venographic findingsunivariate analysisthurner syndromestent placementstent deploymentprospective studiesprognostic significanceprognostic impactprimary outcomepersistent collateralslikely duejanuary 2011independent predictorhazard ratioconfidence intervalbetter outcomesapril 202305 ).021 ).<p>Each graph shows the cumulative primary patency rates among patients with and without specific risk factors. Differences in the survival distribution were assessed using log-rank tests. <b>A.</b> Venous stenosis. Patients with stenosis ≥50% showed significantly lower patency compared to those with <50% stenosis (<i>p</i> < 0.001). <b>B.</b> Venous spur. Presence of luminal irregularity (spur) was associated with inferior patency outcomes (<i>p</i> < 0.001). <b>C.</b> Persistent Collateral Veins. Patients without collateral flow demonstrated significantly higher patency rates than those with persistent collateral flow (<i>p</i> = 0.001). <b>D.</b> Stent placement. Patients who underwent stent placement had a higher long-term patency than those who did not (<i>p</i> = 0.019). <b>E.</b> Stent diameter. Among patients with stent placement, no significant difference in patency was observed between stents ≤12 mm and >12 mm in diameter (<i>p</i> = 0.332).</p>2025-11-25T18:33:04ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1371/journal.pone.0336037.g003https://figshare.com/articles/figure/Kaplan_Meier_curve_showing_24-month_cumulative_primary_patency_stratified_by_venographic_and_procedural_factors_/30714271CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/307142712025-11-25T18:33:04Z |
| spellingShingle | Kaplan–Meier curve showing 24-month cumulative primary patency stratified by venographic and procedural factors. Chang Hoon Oh (16786347) Biochemistry Medicine Cell Biology Molecular Biology Biotechnology Developmental Biology Cancer Infectious Diseases multivariate cox model kaplan &# 8211 iliofemoral dvt secondary effective anatomical resolution 28 – 19 month venous patency related confounding factors meier survival analysis term venous patency independently predict patency hr ]= 5 term patency reduced patency procedural factors independently associated xlink "> whereas 17 venographic findings univariate analysis thurner syndrome stent placement stent deployment prospective studies prognostic significance prognostic impact primary outcome persistent collaterals likely due january 2011 independent predictor hazard ratio confidence interval better outcomes april 2023 05 ). 021 ). |
| status_str | publishedVersion |
| title | Kaplan–Meier curve showing 24-month cumulative primary patency stratified by venographic and procedural factors. |
| title_full | Kaplan–Meier curve showing 24-month cumulative primary patency stratified by venographic and procedural factors. |
| title_fullStr | Kaplan–Meier curve showing 24-month cumulative primary patency stratified by venographic and procedural factors. |
| title_full_unstemmed | Kaplan–Meier curve showing 24-month cumulative primary patency stratified by venographic and procedural factors. |
| title_short | Kaplan–Meier curve showing 24-month cumulative primary patency stratified by venographic and procedural factors. |
| title_sort | Kaplan–Meier curve showing 24-month cumulative primary patency stratified by venographic and procedural factors. |
| topic | Biochemistry Medicine Cell Biology Molecular Biology Biotechnology Developmental Biology Cancer Infectious Diseases multivariate cox model kaplan &# 8211 iliofemoral dvt secondary effective anatomical resolution 28 – 19 month venous patency related confounding factors meier survival analysis term venous patency independently predict patency hr ]= 5 term patency reduced patency procedural factors independently associated xlink "> whereas 17 venographic findings univariate analysis thurner syndrome stent placement stent deployment prospective studies prognostic significance prognostic impact primary outcome persistent collaterals likely due january 2011 independent predictor hazard ratio confidence interval better outcomes april 2023 05 ). 021 ). |